2023-2031 Report on Global T-Cell Immunotherapy Market by Player, Region, Type, Application and Sales Channel

Publisher Name :
Date: 26-Sep-2023
No. of pages: 101

This report studies the T-Cell Immunotherapy market, covering market size for segment by type (CAR-T, TCR, etc.), by application (Stomach Cancer, Lung Cancer, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Adaptimmune Therapeutics, Autolus, Bluebird Bio, CARsgen Therapeutics, Celgene (Juno Therapeutics), etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa).

This report provides detailed historical analysis of global market for T-Cell Immunotherapy from 2017-2022, and provides extensive market forecasts from 2023-2031 by region/country and subsectors. It covers the sales/revenue/value, gross margin, historical growth and future perspectives in the T-Cell Immunotherapy market.

Moreover, the impact of COVID-19 is also concerned. Since outbreak in December 2019, the COVID-19 virus has spread to all around the world and caused huge losses of lives and economy, and the global manufacturing, tourism and financial markets have been hit hard, while the online market/industry increase. Fortunately, with the development of vaccine and other effort by global governments and organizations, the negative impact of COVID-19 is expected to subside and the global economy is expected to recover.

This research covers COVID-19 impacts on the upstream, midstream and downstream industries. Moreover, this research provides an in-depth market evaluation by highlighting information on various aspects covering market dynamics like drivers, barriers, opportunities, threats, and industry news & trends. In the end, this report also provides in-depth analysis and professional advices on how to face the post COIVD-19 period.

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Leading players of T-Cell Immunotherapy including:

- Adaptimmune Therapeutics

- Autolus

- Bluebird Bio

- CARsgen Therapeutics

- Celgene (Juno Therapeutics)

- Cellectis

- Innovative Cellular Therapeutics

- Novartis

- Sinobioway Cell Therapy

- Altor Bioscience Corporation

- Gilead (Kite Pharma)

- Takara Bio

- Unum Therapeutics

- Pfizer

- Aurora BioPharma

- Sorrento Therapeutics

- Mustang Bio

- Collectis

- Allogene Therapeutics

- Celyad

Market split by Type, can be divided into:

- CAR-T

- TCR

- TIL

Market split by Application, can be divided into:

- Stomach Cancer

- Lung Cancer

- Colorectal Cancer

- Esophagus Cancer

- Pancreatic Cancer

Market split by Sales Channel, can be divided into:

- Direct Channel

- Distribution Channel

Market segment by Region/Country including:

- North America (United States, Canada and Mexico)

- Europe (Germany, UK, France, Italy, Russia and Spain etc.)

- Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)

- South America (Brazil, Argentina and Colombia etc.)

- Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)

If you have any special requirements, please let us know and we can provide you the customized report as you want.

2023-2031 Report on Global T-Cell Immunotherapy Market by Player, Region, Type, Application and Sales Channel

Table of Contents

Chapter 1 T-Cell Immunotherapy Market Overview
1.1 T-Cell Immunotherapy Definition
1.2 Global T-Cell Immunotherapy Market Size Status and Outlook (2017-2031)
1.3 Global T-Cell Immunotherapy Market Size Comparison by Region (2017-2031)
1.4 Global T-Cell Immunotherapy Market Size Comparison by Type (2017-2031)
1.5 Global T-Cell Immunotherapy Market Size Comparison by Application (2017-2031)
1.6 Global T-Cell Immunotherapy Market Size Comparison by Sales Channel (2017-2031)
1.7 T-Cell Immunotherapy Market Dynamics
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts
1.7.5 Russia-Ukraine War Impacts

Chapter 2 T-Cell Immunotherapy Market Segment Analysis by Player
2.1 Global T-Cell Immunotherapy Sales and Market Share by Player (2020-2022)
2.2 Global T-Cell Immunotherapy Revenue and Market Share by Player (2020-2022)
2.3 Global T-Cell Immunotherapy Average Price by Player (2020-2022)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player

Chapter 3 T-Cell Immunotherapy Market Segment Analysis by Type
3.1 Global T-Cell Immunotherapy Market by Type
3.1.1 CAR-T
3.1.2 TCR
3.1.3 TIL
3.2 Global T-Cell Immunotherapy Sales and Market Share by Type (2017-2022)
3.3 Global T-Cell Immunotherapy Revenue and Market Share by Type (2017-2022)
3.4 Global T-Cell Immunotherapy Average Price by Type (2017-2022)
3.5 Leading Players of T-Cell Immunotherapy by Type in 2022
3.6 Conclusion of Segment by Type

Chapter 4 T-Cell Immunotherapy Market Segment Analysis by Application
4.1 Global T-Cell Immunotherapy Market by Application
4.1.1 Stomach Cancer
4.1.2 Lung Cancer
4.1.3 Colorectal Cancer
4.1.4 Esophagus Cancer
4.1.5 Pancreatic Cancer
4.2 Global T-Cell Immunotherapy Revenue and Market Share by Application (2017-2022)
4.3 Leading Consumers of T-Cell Immunotherapy by Application in 2022
4.4 Conclusion of Segment by Application

Chapter 5 T-Cell Immunotherapy Market Segment Analysis by Sales Channel
5.1 Global T-Cell Immunotherapy Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel
5.2 Global T-Cell Immunotherapy Revenue and Market Share by Sales Channel (2017-2022)
5.3 Leading Distributors/Dealers of T-Cell Immunotherapy by Sales Channel in 2022
5.4 Conclusion of Segment by Sales Channel

Chapter 6 T-Cell Immunotherapy Market Segment Analysis by Region
6.1 Global T-Cell Immunotherapy Market Size and CAGR by Region (2017-2031)
6.2 Global T-Cell Immunotherapy Sales and Market Share by Region (2017-2022)
6.3 Global T-Cell Immunotherapy Revenue and Market Share by Region (2017-2022)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America T-Cell Immunotherapy Market Share by Type
6.4.3 North America T-Cell Immunotherapy Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico
6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe T-Cell Immunotherapy Market Share by Type
6.5.3 Europe T-Cell Immunotherapy Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain
6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific T-Cell Immunotherapy Market Share by Type
6.6.3 Asia-Pacific T-Cell Immunotherapy Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America T-Cell Immunotherapy Market Share by Type
6.7.3 South America T-Cell Immunotherapy Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa T-Cell Immunotherapy Market Share by Type
6.8.3 Middle East & Africa T-Cell Immunotherapy Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region

Chapter 7 Profile of Leading T-Cell Immunotherapy Players
7.1 Adaptimmune Therapeutics
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.2 Autolus
7.3 Bluebird Bio
7.4 CARsgen Therapeutics
7.5 Celgene (Juno Therapeutics)
7.6 Cellectis
7.7 Innovative Cellular Therapeutics
7.8 Novartis
7.9 Sinobioway Cell Therapy
7.10 Altor Bioscience Corporation
7.11 Gilead (Kite Pharma)
7.12 Takara Bio
7.13 Unum Therapeutics
7.14 Pfizer
7.15 Aurora BioPharma
7.16 Sorrento Therapeutics
7.17 Mustang Bio
7.18 Collectis
7.19 Allogene Therapeutics
7.20 Celyad

Chapter 8 Upstream and Downstream Analysis of T-Cell Immunotherapy
8.1 Industrial Chain of T-Cell Immunotherapy
8.2 Upstream of T-Cell Immunotherapy
8.3 Downstream of T-Cell Immunotherapy

Chapter 9 Development Trend of T-Cell Immunotherapy (2023-2031)
9.1 Global T-Cell Immunotherapy Market Size (Sales and Revenue) Forecast (2023-2031)
9.2 Global T-Cell Immunotherapy Market Size and CAGR Forecast by Region (2023-2031)
9.3 Global T-Cell Immunotherapy Market Size and CAGR Forecast by Type (2023-2031)
9.4 Global T-Cell Immunotherapy Market Size and CAGR Forecast by Application (2023-2031)
9.5 Global T-Cell Immunotherapy Market Size and CAGR Forecast by Sales Channel (2023-2031)

Chapter 10 Appendix
10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification

List of Tables and Figures

Figure T-Cell Immunotherapy Example
Figure Global T-Cell Immunotherapy Revenue (Million $) Status and Outlook (2017-2031)
Figure Global T-Cell Immunotherapy Revenue (Million $) Comparison by Region (2017-2031)
Figure Global T-Cell Immunotherapy Revenue (Million $) Comparison by Type (2017-2031)
Figure Global T-Cell Immunotherapy Revenue (Million $) Comparison by Application (2017-2031)
Figure Global T-Cell Immunotherapy Revenue (Million $) Comparison by Sales Channel (2017-2031)
Table Global T-Cell Immunotherapy Sales by Player (2020-2022)
Table Global T-Cell Immunotherapy Sales Market Share by Player (2020-2022)
Figure Global T-Cell Immunotherapy Sales Market Share by Player in 2022
Table Global T-Cell Immunotherapy Revenue (Million $) by Player (2020-2022)
Table Global T-Cell Immunotherapy Revenue Market Share by Player (2020-2022)
Figure Global T-Cell Immunotherapy Revenue Market Share by Player in 2022
Table Global T-Cell Immunotherapy Average Price by Player (2020-2022)
Figure Global T-Cell Immunotherapy Average Price by Player in 2022
Figure Global T-Cell Immunotherapy Players Competition Situation - Top 5 Players' Revenue Market Share in 2020
Figure Global T-Cell Immunotherapy Players Competition Trends - Top 5 Players' Revenue Market Share in 2022
Figure Example of CAR-T
Figure Global CAR-T Revenue (Million $) and Growth Rate (2017-2022)
Figure Example of TCR
Figure Global TCR Revenue (Million $) and Growth Rate (2017-2022)
Figure Example of TIL
Figure Global TIL Revenue (Million $) and Growth Rate (2017-2022)
Table Global T-Cell Immunotherapy Sales by Type (2017-2022)
Table Global T-Cell Immunotherapy Sales Market Share by Type (2017-2022)
Figure Global T-Cell Immunotherapy Sales Market Share by Type in 2022
Table Global T-Cell Immunotherapy Revenue (Million $) by Type (2017-2022)
Table Global T-Cell Immunotherapy Revenue Market Share by Type (2017-2022)
Figure Global T-Cell Immunotherapy Revenue Market Share by Type in 2022
Table Global T-Cell Immunotherapy Average Price by Type (2017-2022)
Figure Global T-Cell Immunotherapy Average Price by Type in 2022
Table Leading Players of T-Cell Immunotherapy by Type in 2022
Figure Example of Stomach Cancer
Figure Global T-Cell Immunotherapy for Stomach Cancer Revenue (Million $) and Growth Rate (2017-2022)
Figure Example of Lung Cancer
Figure Global T-Cell Immunotherapy for Lung Cancer Revenue (Million $) and Growth Rate (2017-2022)
Figure Example of Colorectal Cancer
Figure Global T-Cell Immunotherapy for Colorectal Cancer Revenue (Million $) and Growth Rate (2017-2022)
Figure Example of Esophagus Cancer
Figure Global T-Cell Immunotherapy for Esophagus Cancer Revenue (Million $) and Growth Rate (2017-2022)
Figure Example of Pancreatic Cancer
Figure Global T-Cell Immunotherapy for Pancreatic Cancer Revenue (Million $) and Growth Rate (2017-2022)
Table Global T-Cell Immunotherapy Sales by Application (2017-2022)
Table Global T-Cell Immunotherapy Sales Market Share by Application (2017-2022)
Figure Global T-Cell Immunotherapy Sales Market Share by Application in 2022
Table Leading Consumers of T-Cell Immunotherapy by Application in 2022
Figure Example of Direct Channel
Figure Global T-Cell Immunotherapy for Direct Channel Revenue (Million $) and Growth Rate (2017-2022)
Figure Example of Distribution Channel
Figure Global T-Cell Immunotherapy for Distribution Channel Revenue (Million $) and Growth Rate (2017-2022)
Table Global T-Cell Immunotherapy Revenue by Sales Channel (2017-2022)
Table Global T-Cell Immunotherapy Revenue Market Share by Sales Channel (2017-2022)
Figure Global T-Cell Immunotherapy Revenue Market Share by Sales Channel in 2022
Table Leading Distributors/Dealers of T-Cell Immunotherapy by Sales Channel in 2022
Table Global T-Cell Immunotherapy Market Size and CAGR by Region (2017-2031)
Table Global T-Cell Immunotherapy Sales by Region (2017-2022)
Table Global T-Cell Immunotherapy Sales Market Share by Region (2017-2022)
Figure Global T-Cell Immunotherapy Sales Market Share by Region in 2022
Table Global T-Cell Immunotherapy Revenue (Million $) by Region (2017-2022)
Table Global T-Cell Immunotherapy Revenue Market Share by Region (2017-2022)
Figure Global T-Cell Immunotherapy Revenue Market Share by Region in 2022
Table North America T-Cell Immunotherapy Sales by Country (2017-2022)
Figure North America T-Cell Immunotherapy Sales Market Share by Country (2017-2022)
Table North America T-Cell Immunotherapy Revenue by Country (2017-2022)
Figure North America T-Cell Immunotherapy Revenue Market Share by Country (2017-2022)
Figure North America T-Cell Immunotherapy Market Share by Type in 2022
Figure North America T-Cell Immunotherapy Market Share by Application in 2022
Figure United States T-Cell Immunotherapy Sales and Growth Rate (2017-2022)
Figure United States T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2017-2022)
Figure Canada T-Cell Immunotherapy Sales and Growth Rate (2017-2022)
Figure Canada T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2017-2022)
Figure Mexico T-Cell Immunotherapy Sales and Growth Rate (2017-2022)
Figure Mexico T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2017-2022)
Table Europe T-Cell Immunotherapy Sales by Country (2017-2022)
Figure Europe T-Cell Immunotherapy Sales Market Share by Country (2017-2022)
Table Europe T-Cell Immunotherapy Revenue by Country (2017-2022)
Figure Europe T-Cell Immunotherapy Revenue Market Share by Country (2017-2022)
Figure Europe T-Cell Immunotherapy Market Share by Type in 2022
Figure Europe T-Cell Immunotherapy Market Share by Application in 2022
Figure Germany T-Cell Immunotherapy Sales and Growth Rate (2017-2022)
Figure Germany T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2017-2022)
Figure UK T-Cell Immunotherapy Sales and Growth Rate (2017-2022)
Figure UK T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2017-2022)
Figure France T-Cell Immunotherapy Sales and Growth Rate (2017-2022)
Figure France T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2017-2022)
Figure Italy T-Cell Immunotherapy Sales and Growth Rate (2017-2022)
Figure Italy T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2017-2022)
Figure Russia T-Cell Immunotherapy Sales and Growth Rate (2017-2022)
Figure Russia T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2017-2022)
Figure Spain T-Cell Immunotherapy Sales and Growth Rate (2017-2022)
Figure Spain T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2017-2022)
Table Asia-Pacific T-Cell Immunotherapy Sales by Country (2017-2022)
Figure Asia-Pacific T-Cell Immunotherapy Sales Market Share by Country (2017-2022)
Table Asia-Pacific T-Cell Immunotherapy Revenue by Country (2017-2022)
Figure Asia-Pacific T-Cell Immunotherapy Revenue Market Share by Country (2017-2022)
Figure Asia-Pacific T-Cell Immunotherapy Market Share by Type in 2022
Figure Asia-Pacific T-Cell Immunotherapy Market Share by Application in 2022
Figure China T-Cell Immunotherapy Sales and Growth Rate (2017-2022)
Figure China T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2017-2022)
Figure Japan T-Cell Immunotherapy Sales and Growth Rate (2017-2022)
Figure Japan T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2017-2022)
Figure Korea T-Cell Immunotherapy Sales and Growth Rate (2017-2022)
Figure Korea T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2017-2022)
Figure India T-Cell Immunotherapy Sales and Growth Rate (2017-2022)
Figure India T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2017-2022)
Figure Southeast Asia T-Cell Immunotherapy Sales and Growth Rate (2017-2022)
Figure Southeast Asia T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2017-2022)
Figure Australia T-Cell Immunotherapy Sales and Growth Rate (2017-2022)
Figure Australia T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2017-2022)
Table South America T-Cell Immunotherapy Sales by Country (2017-2022)
Figure South America T-Cell Immunotherapy Sales Market Share by Country (2017-2022)
Table South America T-Cell Immunotherapy Revenue by Country (2017-2022)
Figure South America T-Cell Immunotherapy Revenue Market Share by Country (2017-2022)
Figure South America T-Cell Immunotherapy Market Share by Type in 2022
Figure South America T-Cell Immunotherapy Market Share by Application in 2022
Figure Brazil T-Cell Immunotherapy Sales and Growth Rate (2017-2022)
Figure Brazil T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2017-2022)
Figure Argentina T-Cell Immunotherapy Sales and Growth Rate (2017-2022)
Figure Argentina T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2017-2022)
Figure Colombia T-Cell Immunotherapy Sales and Growth Rate (2017-2022)
Figure Colombia T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2017-2022)
Table Middle East & Africa T-Cell Immunotherapy Sales by Country (2017-2022)
Figure Middle East & Africa T-Cell Immunotherapy Sales Market Share by Country (2017-2022)
Table Middle East & Africa T-Cell Immunotherapy Revenue by Country (2017-2022)
Figure Middle East & Africa T-Cell Immunotherapy Revenue Market Share by Country (2017-2022)
Figure Middle East & Africa T-Cell Immunotherapy Market Share by Type in 2022
Figure Middle East & Africa T-Cell Immunotherapy Market Share by Application in 2022
Figure UAE T-Cell Immunotherapy Sales and Growth Rate (2017-2022)
Figure UAE T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2017-2022)
Figure Saudi Arabia T-Cell Immunotherapy Sales and Growth Rate (2017-2022)
Figure Saudi Arabia T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2017-2022)
Figure South Africa T-Cell Immunotherapy Sales and Growth Rate (2017-2022)
Figure South Africa T-Cell Immunotherapy Revenue (Million $) and Growth Rate (2017-2022)
Table Company Snapshot of Adaptimmune Therapeutics
Table T-Cell Immunotherapy Introduction of Adaptimmune Therapeutics
Table T-Cell Immunotherapy Sales, Price, Revenue, Gross Margin and Market Share of Adaptimmune Therapeutics (2020-2022)
Table Industrial Chain of T-Cell Immunotherapy
Table Manufacturing Cost Structure of T-Cell Immunotherapy
Table General Manufacturing Process of T-Cell Immunotherapy
Table Leading Distributors/Dealers of T-Cell Immunotherapy
Table Leading Consumers of T-Cell Immunotherapy
Figure Global T-Cell Immunotherapy Sales and Growth Rate Forecast (2023-2031)
Figure Global T-Cell Immunotherapy Revenue and Growth Rate Forecast (2023-2031)
Table Global T-Cell Immunotherapy Market Size and CAGR Forecast by Region (2023-2031)
Table Global T-Cell Immunotherapy Market Size and CAGR Forecast by Type (2023-2031)
Table Global T-Cell Immunotherapy Market Size and CAGR Forecast by Application (2023-2031)
Table Global T-Cell Immunotherapy Market Size and CAGR Forecast by Sales Channel (2023-2031)


  • Global Cancer Immunomodulator Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Cancer Immunomodulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ ......
  • Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size was valued at US$ 14070 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) is forecast to a readjusted size of US$ 57240 million by 2030 with a CAGR of 22.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells (CTCs) and Canc......
  • Global Circulating Tumor Cells Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Circulating Tumor Cells market size was valued at US$ 1550.1 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells is forecast to a readjusted size of US$ 5942.1 million by 2030 with a CAGR of 21.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells market. Circulating Tumor Cells are expected to show stable growth in the future mark......
  • Global Circulating Tumor Cells Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 125
    According to our (Global Info Research) latest study, the global Circulating Tumor Cells market size was valued at USD 1630.5 million in 2023 and is forecast to a readjusted size of USD 5681.6 million by 2030 with a CAGR of 19.5% during review period. Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of......
  • Small Molecule Targeted Cancer Therapy - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 112
    This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Small Molecule Targeted Cancer Therapy, with......
  • Global Cancer Gene Therapy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101
    Market Overview of Global Cancer Gene Therapy market: According to our latest research, the global Cancer Gene Therapy market looks promising in the next 5 years. As of 2022, the global Cancer Gene Therapy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Gene Th......
  • T-Cell Immunotherapy - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 85
    CAR T cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively. The global T-Cell Immunotherapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of T-Cell Immunotherapy in various end use industries. The expanding demands from the Stomach ......
  • Global Kaposi Sarcoma Market Status and Outlook 2023-2028
    Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 107
    Kaposi's sarcoma is a type of cancer that forms in the lining of blood and lymph vessels. The tumors (lesions) of Kaposi's sarcoma typically appear as painless purplish spots on the legs, feet or face. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking a......
  • Global Cancer Immunomodulator Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 118
    Market Overview of Global Cancer Immunomodulator market: According to our latest research, the global Cancer Immunomodulator market looks promising in the next 5 years. As of 2022, the global Cancer Immunomodulator market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cance......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs